Cargando…

A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening

This pilot study sought to evaluate the feasibility of utilizing vaginal self-swabs and urine samples for HPV-based cervical cancer screening in 700 women who had undergone conventional Pap smear screening via the national cervical cancer program in Korea. The cobas 4800 HPV test was utilized to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Sang-Hyun, Shin, Hye Young, Lee, Dong Ock, Sung, Na Young, Lee, Bomyee, Lee, Do-Hoon, Jun, Jae Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998027/ https://www.ncbi.nlm.nih.gov/pubmed/29899531 http://dx.doi.org/10.1038/s41598-018-27390-5

Ejemplares similares

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
por: Liu, Stephanie S., et al.
Publicado: (2022)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Cobas 4800 HPV detection in cervical samples of Polish women
por: Smolarz, Beata, et al.
Publicado: (2019)

Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
por: Shin, Hye Young, et al.
Publicado: (2019)

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media
por: Luo, Hongxue, et al.
Publicado: (2016)

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test
por: Ki, Eun Young, et al.
Publicado: (2012)

Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
por: Ki, Eun Young, et al.
Publicado: (2018)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
por: Cai, Xushan, et al.
Publicado: (2019)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens
por: Martin, Isabella W., et al.
Publicado: (2012)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test
por: Tranberg, Mette, et al.
Publicado: (2018)

Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
por: Jun, Sun-Young, et al.
Publicado: (2015)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Measuring plasma ferritin levels with two different methods: A comparison of Roche Cobas e601 versus Roche Cobas c501 (integrated modular system Roche Cobas 6000)
por: Ayan, Durmuş, et al.
Publicado: (2020)

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples
por: Duan, Lyufang, et al.
Publicado: (2020)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa
por: Dreyer, Greta, et al.
Publicado: (2019)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples
por: Delvallez, Gauthier, et al.
Publicado: (2023)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Sputasol (Dithiothreitol 0.54%) Improves the Detection of Human Papillomaviruses Using the Cobas 4800 System
por: Wang, Qing-Yong, et al.
Publicado: (2017)

Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women
por: Wang, Shanyun, et al.
Publicado: (2020)

Internal quality assurance of HIL indices on Roche Cobas c702
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials
por: Zhang, Yi, et al.
Publicado: (2022)

Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test
por: Lin, Chun-Qing, et al.
Publicado: (2017)

Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020)

Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer
por: Fung, Angela W.S., et al.
Publicado: (2017)

Improved assay protocol for measurement of ammonia on the Roche Cobas 8000 automated platform
por: Kaplon, J., et al.
Publicado: (2018)

Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer
por: Oostendorp, Marlies, et al.
Publicado: (2019)

Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform
por: Larsson, Sara Marie, et al.
Publicado: (2020)

Androgens in women: Establishing reference intervals for dehydroepiandrostenedione sulphate and androstenedione on the Roche Cobas
por: Bokulić, Adriana, et al.
Publicado: (2023)

Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer
por: Wyness, Sara P., et al.
Publicado: (2021)

Evaluation of the Upgraded Version 2.0 of the Roche COBAS(®) AmpliPrep/COBAS(®) TaqMan HIV-1 Qualitative Assay in Central African Children
por: Mossoro-Kpinde, CD, et al.
Publicado: (2016)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19
por: You, Huey-Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ja3975hfnin7jqmcqn1tumctlu